Treatment of metastatic castration-resistant prostate cancer patients with abiraterone acetate and prednisone and corresponding survival prognostic factors

  1. JIMENEZ ROMERO, M.E.
  2. GALLEGO, M.C.
  3. NAVARRO SERRATO, J.C.
  4. SANCHEZ HURTADO, M.A.
  5. SANTOTORIBIO, J.D.
Aldizkaria:
Anticancer Research

ISSN: 1791-7530,  0250-7005

Argitalpen urtea: 2021

Alea: 41

Zenbakia: 8

Orrialdeak: 3955-3968

Mota: Artikulua

DOI: 10.21873/ANTICANRES.15192 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus